The
Senate requests the appointment of a conference committee on:
SB 2308 Parker
/ et al.
SP: Harris / Leach /
Phelan / Orr / VanDeaver / et al.
Relating
to the establishment of a grant program to fund the United States Food
and Drug Administration's drug development trials with ibogaine for the
purpose of securing the administration's approval as a medication for
treatment of opioid use disorder, co-occurring substance use disorder,
and any other neurological or mental health conditions for which ibogaine
demonstrates efficacy.
(Senate Conferees: Parker, Ch./Blanco/Creighton/King/Kolkhorst)
|